PharmaPEG-EPO (Mountain View Pharmaceuticals)

N/A

Report date: 2025/03/20 20:00:06

Base Information

Drug NamePharmaPEG-EPO (Mountain View Pharmaceuticals)
Drug Alias Namepegylated erythropoietin (Mountain View Pharmaceuticals)
ClassificationBiologics
Mechanisms of ActionErythropoietin receptor agonists
TargetsErythropoietin receptor
Therapy Area/IndicationsImmune System DiseasesHematologic Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesMountain View Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesMountain View Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsImmune System DiseasesHematologic Diseases

Other Information

ATC CodeN/A
Related LinksN/A